Nifty

:

25637.80

Sensex

:

84058.90

88.80 (0.35%)
303.03 (0.36%)

Login

Nifty
Sensex

:
:

25637.80
84058.90

88.80 (0.35%)
303.03 (0.36%)

Entero Healthcare Solutions Ltd.

Trading

Rating :

74/99

BSE: 544122 | NSE: ENTERO

Watchlist

NSE BSE

1131.40

27-Jun-2025

Open
High
Low
Previous Close

1119
1146.4
1119
1118.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

35900
40737605.8
1584.25
1038.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,921.29
51.90
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,959.68
N/A
2.85

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.86

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
35.55

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 10.81 21.8 37.34 54.15
P/E Ratio 104.66 51.90 30.30 20.89
Revenue 3922 5096 6628 8270
EBITDA 112 268 374
Net Income 39 95 158 235
ROA 2.1 6.1 7.6
P/B Ratio 3.03 2.56 2.30
ROE 3.5 8.47 11.27
FCFF -99 -24 -86
FCFF Yield -1.87 -0.45 -1.62
Net Debt -555 12 158
BVPS 373.94 442.47 491.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 72.30 106.56 -32.15% 101.15 76.59 32.07% 112.83 73.81 52.87% 122.38 61.20 99.97%
Expenses 84.24 115.75 -27.22% 111.63 85.08 31.21% 118.91 83.00 43.27% 124.23 68.82 80.51%
EBITDA -11.94 -9.19 - -10.48 -8.50 - -6.08 -9.19 - -1.85 -7.62 -
EBIDTM -16.51% -8.62% -10.36% -11.10% -5.38% -12.45% -1.51% -12.45%
Other Income 25.87 42.39 -38.97% 27.51 16.25 69.29% 28.81 16.52 74.39% 32.17 14.76 117.95%
Interest 0.35 5.61 -93.76% 0.37 4.73 -92.18% 0.39 7.32 -94.67% 0.41 4.65 -91.18%
Depreciation 2.16 1.73 24.86% 2.19 2.32 -5.60% 2.13 2.29 -6.99% 2.17 2.41 -9.96%
PBT -35.65 25.87 - 14.47 0.70 1,967.14% 20.22 -2.29 - 27.74 0.09 30,722.22%
Tax -7.85 -11.41 - 3.69 -0.25 - 4.89 -0.14 - 6.87 -2.27 -
PAT -27.81 37.28 - 10.78 0.95 1,034.74% 15.33 -2.14 - 20.88 2.36 784.75%
PATM -38.46% 34.98% 10.66% 1.24% 13.59% -2.90% 17.06% 3.85%
EPS -6.39 8.57 - 2.48 0.22 1,027.27% 3.52 -0.49 - 4.80 0.54 788.89%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,339.06 1,034.18 29.48% 1,359.00 992.63 36.91% 1,300.69 996.30 30.55% 1,097.04 899.20 22.00%
Expenses 1,290.14 1,005.30 28.33% 1,308.98 964.03 35.78% 1,258.24 967.73 30.02% 1,066.86 873.40 22.15%
EBITDA 48.91 28.88 69.36% 50.01 28.60 74.86% 42.45 28.57 48.58% 30.17 25.79 16.98%
EBIDTM 3.65% 2.79% 3.68% 2.88% 3.26% 2.87% 2.75% 2.87%
Other Income 7.29 9.15 -20.33% 7.50 1.79 318.99% 11.28 2.08 442.31% 13.44 1.40 860.00%
Interest 10.49 17.32 -39.43% 9.97 16.07 -37.96% 11.46 17.90 -35.98% 9.70 14.39 -32.59%
Depreciation 8.49 7.14 18.91% 8.10 5.99 35.23% 7.49 5.93 26.31% 6.61 5.95 11.09%
PBT 37.23 13.56 174.56% 39.44 8.32 374.04% 34.78 6.82 409.97% 27.30 6.85 298.54%
Tax 5.80 -7.62 - 9.99 1.34 645.52% 8.74 1.60 446.25% 6.77 0.43 1,474.42%
PAT 31.42 21.18 48.35% 29.45 6.98 321.92% 26.03 5.21 399.62% 20.53 6.43 219.28%
PATM 2.35% 2.05% 2.17% 0.70% 2.00% 0.52% 1.87% 0.72%
EPS 5.90 4.82 22.41% 5.85 4.22 38.63% 5.43 3.19 70.22% 4.62 15.18 -69.57%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 408.66 318.16 177.69 137.29 Net Sales Growth 28.44% 79.05% 29.43% Cost Of Goods Sold 362.21 269.54 154.53 128.44 Gross Profit 46.45 48.62 23.16 8.85 GP Margin 11.37% 15.28% 13.03% 6.45% Total Expenditure 439.01 352.65 221.61 191.00 Power & Fuel Cost - 0.87 0.66 0.57 % Of Sales - 0.27% 0.37% 0.42% Employee Cost - 56.25 43.59 37.92 % Of Sales - 17.68% 24.53% 27.62% Manufacturing Exp. - 0.00 0.00 0.00 % Of Sales - 0% 0% 0% General & Admin Exp. - 16.10 10.54 14.78 % Of Sales - 5.06% 5.93% 10.77% Selling & Distn. Exp. - 8.57 10.37 8.72 % Of Sales - 2.69% 5.84% 6.35% Miscellaneous Exp. - 1.32 1.90 0.58 % Of Sales - 0.41% 1.07% 0.42% EBITDA -30.35 -34.49 -43.92 -53.71 EBITDA Margin -7.43% -10.84% -24.72% -39.12% Other Income 114.36 89.92 52.57 26.87 Interest 1.52 22.32 11.30 5.29 Depreciation 8.65 8.75 9.80 8.71 PBT 26.78 24.36 -12.46 -40.85 Tax 7.60 -14.07 0.00 0.00 Tax Rate 28.38% -57.76% 0.00% 0.00% PAT 19.18 38.44 -12.46 -40.85 PAT before Minority Interest 19.18 38.44 -12.46 -40.85 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 4.69% 12.08% -7.01% -29.75% PAT Growth -50.12% - - EPS 4.41 8.84 -2.86 -9.39

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 5,095.79 3,922.31 3,300.21 2,522.07 Net Sales Growth 29.92% 18.85% 30.85% Cost Of Goods Sold 4,609.48 3,570.36 3,031.87 2,312.44 Gross Profit 486.31 351.96 268.34 209.63 GP Margin 9.54% 8.97% 8.13% 8.31% Total Expenditure 4,924.22 3,810.47 3,236.20 2,497.63 Power & Fuel Cost - 5.59 4.25 4.07 % Of Sales - 0.14% 0.13% 0.16% Employee Cost - 151.15 128.14 114.81 % Of Sales - 3.85% 3.88% 4.55% Manufacturing Exp. - 1.29 1.26 1.22 % Of Sales - 0.03% 0.04% 0.05% General & Admin Exp. - 34.82 30.08 28.85 % Of Sales - 0.89% 0.91% 1.14% Selling & Distn. Exp. - 36.28 29.68 26.01 % Of Sales - 0.92% 0.90% 1.03% Miscellaneous Exp. - 10.98 10.93 10.23 % Of Sales - 0.28% 0.33% 0.41% EBITDA 171.54 111.84 64.01 24.44 EBITDA Margin 3.37% 2.85% 1.94% 0.97% Other Income 39.51 14.41 5.51 4.48 Interest 41.62 65.68 48.97 28.98 Depreciation 30.69 25.02 24.24 19.75 PBT 138.75 35.55 -3.69 -19.81 Tax 31.30 -4.24 7.42 9.63 Tax Rate 22.56% -11.93% -201.08% -48.61% PAT 107.43 39.11 -11.55 -29.92 PAT before Minority Interest 94.81 39.80 -11.10 -29.44 Minority Interest -12.62 -0.69 -0.45 -0.48 PAT Margin 2.11% 1.00% -0.35% -1.19% PAT Growth 169.92% - - EPS 24.70 8.99 -2.66 -6.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,626.41 583.73 551.21 Share Capital 43.49 667.73 622.84 Total Reserves 1,581.15 -83.99 -71.64 Non-Current Liabilities 0.31 45.23 22.92 Secured Loans 0.00 28.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 1.40 1.04 0.75 Current Liabilities 127.82 134.60 79.96 Trade Payables 64.90 55.75 34.75 Other Current Liabilities 61.28 14.02 12.17 Short Term Borrowings 0.00 63.50 30.00 Short Term Provisions 1.65 1.34 3.04 Total Liabilities 1,754.54 763.56 654.09 Net Block 34.44 40.65 51.42 Gross Block 72.11 69.63 72.17 Accumulated Depreciation 37.67 28.98 20.75 Non Current Assets 93.56 90.56 96.81 Capital Work in Progress 0.00 0.00 0.05 Non Current Investment 40.54 40.64 39.43 Long Term Loans & Adv. 13.51 7.87 5.91 Other Non Current Assets 5.06 1.40 0.00 Current Assets 1,660.98 673.00 557.27 Current Investments 0.00 0.00 0.00 Inventories 47.81 28.84 36.23 Sundry Debtors 113.19 74.48 52.23 Cash & Bank 792.35 77.19 88.24 Other Current Assets 707.64 56.68 38.89 Short Term Loans & Adv. 610.56 435.82 341.68 Net Current Assets 1,533.16 538.40 477.31 Total Assets 1,754.54 763.56 654.08

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,638.06 595.03 561.04 Share Capital 43.49 667.73 622.84 Total Reserves 1,592.79 -72.70 -61.80 Non-Current Liabilities 82.62 85.10 100.31 Secured Loans 45.54 31.07 37.13 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 7.11 5.40 4.43 Current Liabilities 601.95 623.96 461.78 Trade Payables 229.91 210.50 139.78 Other Current Liabilities 135.04 67.11 64.91 Short Term Borrowings 230.01 342.45 247.90 Short Term Provisions 6.98 3.90 9.19 Total Liabilities 2,325.96 1,306.72 1,125.30 Net Block 289.34 267.73 261.97 Gross Block 383.26 338.72 311.22 Accumulated Depreciation 93.93 70.99 49.25 Non Current Assets 314.97 283.55 274.42 Capital Work in Progress 0.00 0.00 0.64 Non Current Investment 0.00 0.00 0.00 Long Term Loans & Adv. 20.20 14.42 11.81 Other Non Current Assets 5.44 1.40 0.00 Current Assets 2,010.97 1,023.17 850.88 Current Investments 0.00 0.00 0.00 Inventories 421.15 341.63 310.16 Sundry Debtors 615.40 514.88 374.60 Cash & Bank 893.18 106.84 105.40 Other Current Assets 81.23 23.17 24.35 Short Term Loans & Adv. 40.71 36.65 36.38 Net Current Assets 1,409.03 399.21 389.10 Total Assets 2,325.94 1,306.72 1,125.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity -75.65 -56.91 -44.70 PBT 24.36 -12.46 -40.85 Adjustment -38.43 -29.51 -9.38 Changes in Working Capital -59.79 -12.41 6.49 Cash after chg. in Working capital -73.86 -54.38 -43.74 Interest Paid 0.00 0.00 0.00 Tax Paid -1.79 -2.53 -0.96 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -762.69 -58.29 -68.80 Net Fixed Assets -2.48 2.59 Net Investments 0.10 -1.21 Others -760.31 -59.67 Cash from Financing Activity 925.56 91.11 127.48 Net Cash Inflow / Outflow 87.22 -24.09 13.98 Opening Cash & Equivalents 6.12 30.20 16.22 Closing Cash & Equivalent 93.34 6.12 30.20

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity -36.61 -45.31 -35.27 PBT 35.55 -3.69 -19.81 Adjustment 86.62 71.16 41.52 Changes in Working Capital -145.73 -100.36 -46.07 Cash after chg. in Working capital -23.55 -32.89 -24.36 Interest Paid 0.00 0.00 0.00 Tax Paid -13.06 -12.43 -10.90 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -705.12 -48.59 -161.73 Net Fixed Assets -2.48 2.59 Net Investments 0.10 -1.21 Others -702.74 -49.97 Cash from Financing Activity 862.94 72.76 211.19 Net Cash Inflow / Outflow 121.21 -21.15 14.19 Opening Cash & Equivalents 25.36 46.51 32.31 Closing Cash & Equivalent 147.65 25.36 46.51

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 373.53 -194.27 -176.06 ROA 3.05% -1.76% -6.88% ROE 4.98% 0.00% 0.00% ROCE 4.06% -0.18% -6.66% Fixed Asset Turnover 4.49 2.51 2.04 Receivable days 107.65 130.14 110.45 Inventory Days 43.97 66.83 111.15 Payable days 81.69 106.88 67.76 Cash Conversion Cycle 69.92 90.10 153.84 Total Debt/Equity 0.00 0.16 0.05 Interest Cover 2.09 -0.10 -6.72

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 376.21 -166.80 -150.52 ROA 2.19% -0.91% -3.01% ROE 5.08% 0.00% 0.00% ROCE 7.02% 4.99% 1.24% Fixed Asset Turnover 10.87 10.16 9.53 Receivable days 52.59 49.19 44.63 Inventory Days 35.49 36.04 40.09 Payable days 22.51 21.08 18.67 Cash Conversion Cycle 65.57 64.15 66.06 Total Debt/Equity 0.17 0.63 0.51 Interest Cover 1.54 0.92 0.32

Top Investors:

surbhi singh(prasid uno family trust)

invesco india aggressive hybrid fund

smallcap world fund, inc

government of singapore

stichting depositary apg emerging markets equity pool

Annual Reports:

News Update:

Entero Healthcare Solutions gets nod to acquire 80% stake in Anand Medical Distributors
28th May 2025, 10:13 AM

The company’s board has approved the further acquisition of 8000 equity shares of Peerless Biotech
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback